Pulse Biosciences, Inc. (PLSE) Profit Margins
Over the twelve months to 2026-06-30, Pulse Biosciences, Inc. (PLSE) had operating margin -7007.8%, net margin -6755.8%, free cash flow margin -5180.4%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PLSEPulse Biosciences, Inc.Follow PLSE — free
—
Price chart with a free account
- Market cap
- 3.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Gross margin | -38.8% | -1606.3% | -54.0% | — | |
| Operating margin | -4443.9% | -8293.9% | -21982.6% | -7007.8% | |
| Net margin | -4489.4% | -8357.9% | -20794.6% | -6755.8% | |
| FCF margin | -3845.8% | -6773.4% | -15553.4% | -5180.4% |
USD millions · SEC XBRL
Pulse Biosciences, Inc. — questions
- What is Pulse Biosciences, Inc.'s operating margin?
- -7007.8% over the twelve months to 2026-06-30.
- What is Pulse Biosciences, Inc.'s net profit margin?
- -6755.8% over the twelve months to 2026-06-30.
Every figure on this page comes from Pulse Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.